Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global anticoagulants market reached a value of US$ 34.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting a CAGR of 10.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Blood clots form when blood thickens and forms a semi-solid mass in any part of the body. This causes serious problems, such as stroke, heart attack, pulmonary embolism, transient ischemic attacks, and deep vein thrombosis (DVT). As a result, doctors around the world are prescribing anticoagulant drugs to people who are at a high risk of clot formation. These drugs help in thinning blood, preventing or reducing blood clotting, and prolonging the clotting time. They are usually available in capsule or tablet form, including warfarin, rivaroxaban, dabigatran and apixaban.
Anticoagulants Market Trends:
Recent research indicates that hypercoagulability in individuals affected by the coronavirus disease (COVID-19) pandemic can be one of the leading causes of mortality worldwide. As a result, its surging cases are positively influencing the demand for anticoagulant drugs to treat the thrombotic condition among critically ill or hospitalized patients. Moreover, certain risk factors, such as extended sitting, smoking, trauma, blood disorders, and autoimmune diseases, can cause blood clotting in different parts of the body. This, in confluence with the increasing prevalence of human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, and chronic inflammation, represents another significant factor strengthening the growth of the market. Apart from this, the growing aging population across the globe is resulting in the escalating demand for surgical services. Surgeries often require prolonged bed rest, which, in turn, increases the risk of blood clotting and the overall sales of anticoagulant drugs. Furthermore, the improving diagnosis rates and the escalating demand for target therapeutics are fueling the market growth. The emergence of online pharmacies is also driving the demand for anticoagulant drugs around the world.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, route of administration, distribution channel and application.
Breakup by Drug Class:
Novel Oral Anticoagulants (NOACs)
Heparin and Low Molecular Weight Heparin (LMWH)
Vitamin K Antagonist
Others
Breakup by Route of Administration:
Oral Anticoagulant
Injectable Anticoagulant
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
Breakup by Application:
Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc. and Sanofi.
Key Questions Answered in This Report:
How has the global anticoagulants market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global anticoagulants market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global anticoagulants market and who are the key players?
What is the degree of competition in the industry?
Blood clots form when blood thickens and forms a semi-solid mass in any part of the body. This causes serious problems, such as stroke, heart attack, pulmonary embolism, transient ischemic attacks, and deep vein thrombosis (DVT). As a result, doctors around the world are prescribing anticoagulant drugs to people who are at a high risk of clot formation. These drugs help in thinning blood, preventing or reducing blood clotting, and prolonging the clotting time. They are usually available in capsule or tablet form, including warfarin, rivaroxaban, dabigatran and apixaban.
Anticoagulants Market Trends:
Recent research indicates that hypercoagulability in individuals affected by the coronavirus disease (COVID-19) pandemic can be one of the leading causes of mortality worldwide. As a result, its surging cases are positively influencing the demand for anticoagulant drugs to treat the thrombotic condition among critically ill or hospitalized patients. Moreover, certain risk factors, such as extended sitting, smoking, trauma, blood disorders, and autoimmune diseases, can cause blood clotting in different parts of the body. This, in confluence with the increasing prevalence of human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, and chronic inflammation, represents another significant factor strengthening the growth of the market. Apart from this, the growing aging population across the globe is resulting in the escalating demand for surgical services. Surgeries often require prolonged bed rest, which, in turn, increases the risk of blood clotting and the overall sales of anticoagulant drugs. Furthermore, the improving diagnosis rates and the escalating demand for target therapeutics are fueling the market growth. The emergence of online pharmacies is also driving the demand for anticoagulant drugs around the world.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global anticoagulants market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, route of administration, distribution channel and application.
Breakup by Drug Class:
Novel Oral Anticoagulants (NOACs)
Heparin and Low Molecular Weight Heparin (LMWH)
Vitamin K Antagonist
Others
Breakup by Route of Administration:
Oral Anticoagulant
Injectable Anticoagulant
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
Breakup by Application:
Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc. and Sanofi.
Key Questions Answered in This Report:
How has the global anticoagulants market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global anticoagulants market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global anticoagulants market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTICOAGULANTS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Novel Oral Anticoagulants (NOACs)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Heparin and Low Molecular Weight Heparin (LMWH)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Vitamin K Antagonist
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Oral Anticoagulant
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectable Anticoagulant
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Atrial Fibrillation and Heart Attack
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stroke
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Deep Vein Thrombosis (DVT)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Pulmonary Embolism (PE)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Alexion Pharmaceuticals Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Aspen Holdings
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Boehringer Ingelheim International GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Daiichi Sankyo Company Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Dr. Reddy’s Laboratories Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Johnson & Johnson Private Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTICOAGULANTS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Novel Oral Anticoagulants (NOACs)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Heparin and Low Molecular Weight Heparin (LMWH)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Vitamin K Antagonist
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
7.1 Oral Anticoagulant
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectable Anticoagulant
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Atrial Fibrillation and Heart Attack
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stroke
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Deep Vein Thrombosis (DVT)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Pulmonary Embolism (PE)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Alexion Pharmaceuticals Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Aspen Holdings
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Boehringer Ingelheim International GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Daiichi Sankyo Company Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Dr. Reddy’s Laboratories Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Johnson & Johnson Private Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players
Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players
LIST OF FIGURES
Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2021
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2021
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis
Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2021
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2021
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis
